ZY

Zymergen Inc. Common Stock
ZY

Delisted

ZY was delisted on the 18th of October, 2022.

Back to rankings
 

About: Zymergen Inc is a biofacturing company. Zymergen partners with nature to design, develop and manufacture bio-based breakthrough products that deliver value to customers in a broad range of industries. A unique combination of biology, chemistry, software and automation enables the company to design and create new materials.

Employees: 507

Healthcare Diagnostics & Research

Financial journalist opinion

Neutral
Newsfile Corp
8 months ago
SEC Charges Zymergen Inc. With Misleading IPO Investors About Company's Market Potential and Sales Prospects
Washington, D.C.--(Newsfile Corp. - September 13, 2024) - The Securities and Exchange Commission today announced settled charges against Zymergen Inc., an Emeryville, California-based biotechnology company, for misleading IPO investors about its overall market potential, revenue prospects, and customer pipeline for its only commercially available product, an electronics film named Hyaline.
SEC Charges Zymergen Inc. With Misleading IPO Investors About Company's Market Potential and Sales Prospects
See News Rankings
Charts implemented using Lightweight Charts™